BellRock Brands Inc. has entered into a licensing agreement with Motacann Holdings, LLC to bring its Dixie and Mary's Medicinals brands to Missouri.
Execution of the agreement coincides with Motacann's proposed sale of its infused product manufacturing license to BRB Missouri, LLC, a BellRock strategic partner, subject to Missouri Department of Health and Senior Services approval. The sale of the license, if approved, will offer the company a lasting presence in Missouri. BellRock's entrance into the state exemplifies BellRock's focus on driving organic growth and expanding its reach through new and maturing markets. The company's brands are expected on shelves by the end of summer 2022.
Additionally, BellRock has made the strategic decision to exit the Florida market to focus on its Midwest presence.
"Missouri is an attractive new market, and we anticipate BellRock will benefit from an early mover advantage," said Brian Jansen, CEO of BellRock Brands. "With Missouri and our recently announced Ohio partnership, we continue to build our presence in the U.S. cannabis markets. Our goal has always been to build a national cannabis house of brands that is seen as an industry powerhouse and expanding into Missouri helps bring this to fruition."
BellRock has also announced two new products to its Dixie gummy line: SYNERGY Berry Focused and SYNERGY Sleepberry.
SYNERGY Berry Focused gummies contain a balanced cannabinoid blend of CBG, CBD, THC, and a special terpene profile aimed at supporting alertness and focus. SYNERGY Sleepberry utilizes a ratioed cannabinoid profile of CBN, CBD, and THC, as well as melatonin (where permitted) and a proprietary terpene blend.
SYNERGY Berry Focused and SYNERGY Sleepberry can be found in Colorado, California, and Michigan, with plans to introduce the products in other U.S. cannabis markets by the end of 2022.